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ABSTRACT
This paper describes a simple, hazard-free and inexpensive procedure
that allows researchers to send cultured cells across the globe at
ambient temperatures. The method enables transit of up to 2 weeks
without compromising cell recovery. Its use will assist collaborators in
distant laboratories to exchange cells without using dry-ice.
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INTRODUCTION
For many decades, the conventional method of sending cells from A
to B globally has been as frozen samples dispatched by courier in
several kilograms of dry-ice. From storage to delivery, the cost is high
and the procedure hazardous, with many couriers refusing to take
cargo on dry-ice. Delay in transit is common (e.g. slow customs
inspection), and when this occurs the dry-ice often evaporates,
leaving the cells bathed in cryoprotectant (10% DMSO), which is
cytotoxic at ambient temperatures. While cell culture facilities will
most likely continue to use this mode of shipping because their
collections are held in liquid nitrogen, other methods are becoming
available that minimise these frustrations and maximise cell recovery
post transit. They also have the added advantage of eliminating the
large CO2 emission associated with using dry-ice. Some researchers
simply send culture flasks of cells filled with medium and tightly
secured caps, but here agitation can cause cell monolayers to detach;
however, more importantly, liquids pose a spill hazard, and are
prohibited in the mail and air travel. To circumvent these issues, we
and others have turned to gel-based medium to transport biological
samples, as published in a broad patent in 2002 (Baust et al., 2002),
and found in Bagasra et al. (1985), Brendel et al. (1994) and Stevens
et al. (2005). Undoubtedly there is a need for a simple, inexpensive
and non-hazardous method of transporting cell cultures between
collaborators, particularly in this era in which designer cell lines are
becoming centre stage. What follows is a brief description of a tried
and tested method we have devised that can fulfil this need.
RESULTS AND DISCUSSION
First, to demonstrate the risk of sending cells on dry-ice, three cell lines
were resuspended in 90% fetal calf serum (FCS) with 10% DMSO
and held on dry-ice for 7 days. For one vial of each line, the dry-ice
was regularly replenished, but for the other samples it evaporated
completely within ∼4 days. Cell viability was assessed 72 h
post-seeding, using the metabolic resazurin-based assay. Recovery
from frozen was successful when the dry-ice was maintained
throughout transit, but recovery was poor (RPE) or non-existent
(U2OS and HeLa) when the dry-ice had expired (Fig. 1A).
We have compared the efficacy of recovery between cells held on
dry-ice and those in our ‘Transporter’. Four cell lines were
resuspended in either 90% FCS with 10% DMSO and placed on
dry-ice (replenished) or in Transporter held at constant temperatures
of 0°C (ice), 4°C, ∼20°C (ambient) or 37°C. After 72 h incubation,
cell viability was assessed using resazurin. All cell lines recovered
better in Transporter than on dry-ice when previously kept at 0°C,
4°C or 20°C (Fig. 1B), which is also evident from their morphology
when reattached and growing in Petri dishes (Fig. 1C). Recovery
after 72 h transit at 37°C in Transporter was cell line dependent,
with untransformed NIH 3T3 (mouse fibroblasts) and RPE cells
(human retinal epithelial) recovering successfully (Fig. 1B). For
transformed cell lines (e.g. HeLa and A549), transportation for
7 days up to 27°C was well tolerated, but temperatures of 32°C
and above were not. The most robust cells tolerated up to 3 weeks
of transport (e.g. U2OS and MRC5) at ambient temperature
(20–22°C). A summary of similar findings using eight different cell
lines kept for different lengths of time in Transporter is shown in
Table 1. [However, not all cell lines will necessarily respond in the
exactly the same way, and thus it is worth checking carefully
beforehand their ability to endure the conditions of transportation.]
Further experiments were carried out to determine the optimal cell
density and maximum duration tolerated in transit. To determine the
optimum cell density, we assessed cell viability post-transit for three
cell lines transported for 72 h at ambient temperature at 106, 10×106
or 20×106 cells per ml. Notably, although RPE and U2OS cells fared
similarly at all densities, HeLa cells did not survive well at
20×106 cells/ml (Fig. 1D). When transit was carried out at 4°C, all
three lines did less well at 106 cells/ml (data not shown); therefore
subsequent experiments were carried out with cells at between 106
and 107 cells/ml, with the preferred density being 5×106 cells/ml.
Growth curves for HeLa and U2OS cells recovering after 3 days
storage in Transporter at different temperatures are shown in Fig 1E,F.
When cell viability was compared between cells transported for 72 h
versus 240 h, for all four cell lines tested there was a decline in cell
viability (Fig. S1B), indicating that shorter transit is better and
providing some evidence that these cells do not proliferate when
transported at ambient temperature.
Having established that immortalised cell lines could tolerate
transportation in this way, we next asked whether primary cells
would also survive. Rat astrocytes (Fig. 2A,B) and human
myoblasts (Fig. 2C), were seeded 24 h prior to imaging either
directly from the stock flasks (no transportation) or after 72 h in
Transporter. Phase imaging demonstrated that recovery was
excellent in each case and cells looked similar regardless of
whether they had been transported or simply passaged. Moreover, to
prove that astrocytes retained their normal and defining
characteristics after transport, we immunostained them with anti-
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(Fig. 2B). Thus, Transporter can also be used for primary cell
transit, at least for up to 72 h.
Given that organisms, such as zebrafish (Percival and Parant,
2016), organoids and eggs (Udan et al., 2014) are routinely
immobilised in agarose for analysis by live fluorescence confocal
and light sheet imaging, it is unsurprising that this method is so
effective. Indeed, our Transporter medium is similar in many respects
to the natural gel of amphibian eggs, which supports development to
the juvenile stage of the animal. Our Transporter has successfully
supported the carriage of developing Drosophila (data not shown).
Fig. 1. Cells can be transported without dry ice. (A) The cell lines indicated were incubated on dry-ice in 90% FCS with 10% DMSO for 7 days and cell viability
(expressed in relative fluorescence units, RFU) was assessed using the resazurin assay. (B) The cell lines (5×106/ml) indicated were incubated in FCS in DMSO
and held on dry-ice or resuspended in Transporter (Tsprt) and incubated at different temperatures before viability was assessed, as in A. (C) Phase-contrast
images of recovering cells after 7 days in Transporter and seeded 72 h before imaging (HeLa and PANC2), or 96 h in Transporter and imaged 24 h post seeding
(MRC5). Scale bars: 100 µm. (D) Cells were transported at three different densities at ambient temperature and cell viability assessed 24 h post-seeding. Graphs
show mean±s.d within a single experiment representative of n=3 independent experiments. (E,F) Growth of HeLa (E) and U2OS (F) cells over 4 days after being
kept in Transporter for 3 days at the indicated temperatures. All graphs show representative experiments performed at least three independent times. Internal
repeats were carried out in quadruplicate, bars/points indicated the mean, and error bars show s.d. within the representative experiment.
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Thus, it will be interesting to determine whether this method can aid
the transit of germ cells (Hatakeyama et al., 2017) – which would aid
breeding programmes – and stem cells, which would be medically
beneficial, as also to others, such as veterinarians. Should Transporter
support the preservation of small pieces of tissues (biopsies and
organs), this would have huge medical implications, with the most
immediate benefactors being transplant patients. And finally,
Transporter could also be adopted to improve containment of
species presenting biological safety hazards that need to be shipped
across the globe for diagnostic purposes.
Conclusion
We have disclosed a simple, inexpensive and non-hazardous
method for sending cultured cells between laboratories. While there
is some variation in survival depending upon cell type, excellent
recovery is seen when cells are transported at 5×106 cells/ml within
Table 1. Recovery outcomes of ten cell types after incubation in Transporter for the indicated times and temperatures
Cell line Type Duration (days) Temperature (°C) and recovery
Astrocytes Rat primary 3 20–22 (yes)
A549 Lung cancer 5 0–4 (yes), 20–22 (yes), 37 (yes)
EJ30 Bladder cancer 5 0–4 (yes), 20–22 (yes), 27 (yes), 32 (poor)
HeLa Cervical cancer 3–7 0–4 (yes), 20–22 (yes), 37 (poor)
MDA231 Breast cancer 3 0–4 (yes), 20–22 (yes), 27 (yes), 32 (poor)
MRC5 Normal lung fibroblast 5–7 0–4 (yes), 20–22 (yes), 37 (poor)
Myoblasts Human primary 3 20–22 (yes)
NIH-3T3 Murine fibroblast 3–7 0–4 (yes), 20–22 (yes), 37 (yes)
RPE Normal human retinal pigmental epithelial 3–7 0–4 (yes), 20–22 (yes), 27 (yes), 32 (poor), 37 (poor)
U2OS Osteosarcoma 3–5 0–4 (yes), 20–22 (yes), 32 (poor), 37 (no)
Yes, excellent recovery within 7 days; poor, recovery took more than 7 days; no, no recovery.
Fig. 2. Primary cells can tolerate 72 h
transit in Transporter. (A,B) Rat
astrocytes were either trypsinised and
seeded (no transportation) or incubated
in Transporter for 72 h then seeded, and
imaged in phase contrast (A) 24 h later
or (B) to prove that they retained their
astrocytic characteristics, they were
fixed and immunostained for GFAP
and imaged using a fluorescence
microscope. (C) Human myoblasts were
treated in the sameway as rat astrocytes
in A. Scale bars: 20 µm.
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the temperature range 4–27°C for 7 days, and where tested there have
been cases of very good recovery after 3 weeks at ambient
temperature (20–22°C). For the best results, we recommend
sending cells in small aliquots of Transporter (100 µl) in microfuge
tubes at 5×106 cells/ml, ensuring that the gel pellet is dispersed as
fully as possible prior to seeding.
Proof of principle was established on three occasions, with cells
being taken as hand-luggage in transit (for up to 5 days) from the
UK to Hong Kong, where excellent, fast recovery was observed
after seeding. The method has since been successfully trialled by at
least seven independent colleagues.
MATERIALS AND METHODS
Cell culture
All cells (having been tested as mycoplasma free) were cultured in DMEM
with 10% fetal calf serum (FCS), supplemented with 1% glutamine and 1%
antibiotic and antimycotic, herein referred to as ‘1× complete DMEM’.
Cells were maintained at 37°C in a humid incubator with 5% CO2 in air.
Prior to transit, cells were harvested by trypsinisation, pelleted by
centrifugation (500 g for 3 min), and resuspended at 0.5×107–1×107 cells/
ml in 1× complete DMEM. Rat astrocytes were isolated (ethical approval
AWERB ref 000148) and cultured in DMEM supplemented with 500 μg/ml
proline as described previously (James et al., 2011). Human myoblasts were
isolated with University of Nottingham ethical approval (G11092014SoLS)
and cultured in F10/HAMS with 20% FCS (O’Leary et al., 2018). Cell
culture reagents were supplied by Thermo Fisher Scientific, unless stated
otherwise. The following cell lines have been used, although not all will be
referred to in this report: normal lines, RPE-1, human retinal pigmented
epithelial; 3T3, murine fibroblast; MRC5, human lung fibroblasts; and
HEK293: human embryonic kidney; malignant (human) cell lines, HeLa:
cervical; U2OS, osteosarcoma; Hct116, colorectal; MDA-MB231, breast;
SKBR3, breast; EJ30, bladder; and MCF7, breast.
Primary cell lines
Rat astrocytes were a gift from Andrew Bennett, SoLS, Nottingham, UK;
human myoblasts (O’Leary et al., 2018) were a gift from Kostas Tsintzas,
SoLS, Nottingham, UK.
Preparation of ‘Transporter’
A 2% solution of low-melting temperature (LMT) agarose (Sigma-Aldrich
catalogue number A9414) was prepared in PBS, sterilised by autoclaving,
cooled and supplemented with filter-sterilised HEPES at 20 mM (pH 7.4),
then held at 37°C ready for the addition of cells. Reagents were supplied by
Sigma-Aldrich.
Cells in ‘Transporter’
Cells at 1×107 cells/ml resuspended in complete DMEM were mixed 1:1
with pre-warmed Transporter, pipetted into 1.5 ml microfuge tubes in
∼100 µl aliquots, and sealed with parafilm (Fig. S1C). When using PBS as
the diluent for LMT agarose, 1× complete medium, as normally used for the
particular cell type, is recommended. If LMT is constituted in water, then
2× complete medium should be used to ensure the carrier is isotonic;
however, this will require medium to be prepared from powdered stock.
The tubes were put into ‘Jiffy’ bags (size A) and sent to their destinations
by regular mail, air-mail or courier, with associated documentation.
Recovery
Upon receipt, the microfuge tubes containing the cells are placed on a heat-
block at 37°C, and 1 ml of pre-warmed complete mediumwas added, and the
gel pellet thoroughly dispersed by pipetting intermittently for 5–10 min. The
cells were then seeded on to Petri dishes, welled plates, culture flasks or onto
live imaging chambers with pre-warmed medium in the usual manner.
Resazurin assay
To assess cell recovery, cell number was monitored using a standard
resazurin assay. Briefly, cells were seeded into 96-well plates in
quadruplicate, and incubated for 1 h at 37°C with 10 µg/ml resazurin
diluted in complete DMEM before being read on a Fluostar Galaxy
spectrophotometer with excitation set at 530 nm and emission to 590 nm.
Note that each cell line has a different metabolic profile (Fig. S1A), therefore
the heights of the bars should only be compared within the dataset for a
single cell type.
Imaging
Phase-contrast imaging
Cell attachment and morphology was followed using a standard inverted
Nikon microscope fitted with a ×20 or ×40 objective, and imaged in phase-
contrast using a Nikon D3000 camera.
Fluorescence imaging
Primary cells, grown in Ibidi live imaging chambers, were washed with pre-
warmed PBS, fixed with 4% formaldehyde/PBS (5 min, 37°C),
permeabilised with 0.15% Triton X-100 in PBS (2 min, 37°C), blocked
with PBS/1%BSA/azide (15 min, RT) and immunostained to visualise the
astrocyte specific marker glial fibrillary acid protein (GFAP), with anti-
GFAP antibodies, (Cell Signaling Technology, mouse monoclonal GA5;
1:300; 1 h, room temperature), followed by 1:200 fluorescein conjugated
anti-mouse-Ig (Vector, 1:200). Images were acquired using an Olympus
IX71 microscope fitted with a ×40 (NA 1.3) oil objective, using Deltavision
software and a CoolSnap camera. A single deconvolved 0.3 µm optical
section is shown. TIFF images were prepared in ImageJ.
Cell Transporter protocol
Sending cells
1. Prepare a 2% solution of low-melting temperature (LMT) agarose
(Sigma-Aldrich, cat. no. A9414) in PBS, dissolve and sterilise by
autoclaving, then cool to 37°C.
2. Under sterile conditions add HEPES to a final concentration of
20 mM (pH 7.4), mix, aliquot (see additional notes) and store, or use
immediately.
3. Harvest exponentially growing adherent cells by trypsinisation and re-
suspend at 107 cells/ml in the regular complete medium used for that
cell line.
4. Pipette 50 µl sterile LMT agarose into a pre-warmed 1.5 ml microfuge
tube.
5. Pipette 50 µl of the cell suspension into the warm LMT solution and
mix gently by pipetting (1:1 cell to LMT ratio). Place on rack at room
temperature to cool until gel forms (30–60 s).
6. Seal tube with parafilm and place in padded envelope with associated
documentation.
7. Send via mail, air-mail or courier, aiming for arrival at destination in
preferably less than 1 week.
Receiving cells
1. Under sterile conditions, add 1 ml of pre-warmed complete medium
to the microfuge tube, pipette to disperse and break the gel pellet.
2. Incubate at 37°C for a further 15–30 min. Re-pipette until the gel has
been fully dispersed.
3. Transfer to awaiting tissue culture vessel and culture using normal
procedures.
Additional notes
1. 2% LMT/HEPES can be stored at 4–22°C for 2 months. Do not
freeze. LMT can be re-melted by microwaving gently for several
seconds or heating to 60°C. Cool to 37°C before use. 1–2 ml aliquots
made in 5 ml tubes are most convenient for cell culture.
2. By placing solution on a rack in step 4 (sending), the pellet forms at
the bottom of the tube. This minimises evaporation, and, if cells are
no longer a discrete pellet at the destination, will suggest that a
temperature of >37°C was exceeded during transit.
3. Optimal density may vary with cell type.
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4. The procedure can be scaled up, but ensure that there is sufficient
space for the addition of 10 volumes of medium upon receipt.
5. Efficiency of recovery improves with greater dispersion of the
gel pellet.
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